IL1B and COVID-19: Inflammation is a key feature of COVID‐19, which has been characterized as a highly inflammatory disease with elevated levels of proinflammatory molecules, including caspase‐1, IL‐1β, IL‐6, IL‐18, and TNF‐ɑ, particularly in more severe manifestations [33].